AGA releases official guidance for patients with IBD during the COVID-19 pandemic

AGA releases official guidance for patients with IBD during the COVID-19 pandemic
Management of Patients with IBD during the COVID-19 Pandemic Credit: American Gastroenterology Association

Today, the American Gastroenterological Association (AGA) published new COVID-19 guidance for gastroenterologists treating patients with inflammatory bowel disease (IBD): AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert Commentary.

While the COVID-19 pandemic is a global health emergency, patients with IBD have particular concerns for their risk for infection and management of their medical therapies. This clinical practice update incorporates the emerging understanding of COVID-19 and summarizes available guidance for patients with IBD and the providers who take care of them.

Recommendations for gastroenterologists & their patients who have IBD:

1. During this pandemic, patients with IBD should continue IBD therapies including scheduled infusions.

2. Having IBD does not appear to increase the risk of SARS-CoV-2 infection or the development of COVID-19.

3. Instructions for with IBD who develop COVID-19 (fever, respiratory symptoms, digestive symptoms, etc.):

a. Stop thiopurines, methotrexate, tofacitinib.

b. Stop biological therapies (including anti-TNF, ustekinumab, vedolizumab).

c. Can restart therapies after complete resolution of COVID-19 symptoms. Patients should

always speak with their health care team before stopping any medication.

4. Doctors should submit cases of IBD and confirmed COVID-19 to the SECURE-IBD registry at COVIDIBD.org.

AGA releases official guidance for patients with IBD during the COVID-19 pandemic
Management of IBD During the COVID-19 Pandemic. Credit: American Gastroenterology Association

Explore further

Follow the latest news on the coronavirus (COVID-19) outbreak

More information: David T. Rubin et al, AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert Commentary, Gastroenterology (2020). DOI: 10.1053/j.gastro.2020.04.012
Journal information: Gastroenterology

Citation: AGA releases official guidance for patients with IBD during the COVID-19 pandemic (2020, April 11) retrieved 11 July 2020 from https://medicalxpress.com/news/2020-04-aga-guidance-patients-ibd-covid-.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
7 shares

Feedback to editors

User comments